Bank of Montreal’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$774K Sell
7,820
-21
-0.3% -$1.89K ﹤0.01% 2219
2026
Q1
$680K Sell
7,841
-14,632
-65% -$1.28M ﹤0.01% 2246
2025
Q4
$1.91M Buy
22,473
+4,781
+27% +$382K ﹤0.01% 1674
2025
Q3
$1.28M Buy
17,692
+11,006
+165% +$759K ﹤0.01% 1850
2025
Q2
$438K Sell
6,686
-1,076
-14% -$70K ﹤0.01% 2351
2025
Q1
$548K Sell
7,762
-5,164
-40% -$359K ﹤0.01% 2142
2024
Q4
$849K Buy
12,926
+7,412
+134% +$510K ﹤0.01% 1950
2024
Q3
$386K Sell
5,514
-131
-2% -$9.13K ﹤0.01% 2585
2024
Q2
$381K Sell
5,645
-6,424
-53% -$421K ﹤0.01% 2589
2024
Q1
$821K Sell
12,069
-4,344
-26% -$287K ﹤0.01% 2120
2023
Q4
$1.02M Buy
16,413
+10,665
+186% +$627K ﹤0.01% 2033
2023
Q3
$365K Sell
5,748
-55,848
-91% -$3.43M ﹤0.01% 2668
2023
Q2
$3.69M Buy
61,596
+54,783
+804% +$3.26M ﹤0.01% 1485
2023
Q1
$411K Sell
6,813
-135
-2% -$8.13K ﹤0.01% 2572
2022
Q4
$434K Sell
6,948
-1,530
-18% -$92K ﹤0.01% 2690
2022
Q3
$506 Buy
8,478
+2,385
+39% +$147K ﹤0.01% 2574
2022
Q2
$398 Buy
6,093
+1,434
+31% +$91K ﹤0.01% 2833
2022
Q1
$306K Sell
4,659
-120
-3% -$7.61K ﹤0.01% 3173
2021
Q4
$319K Hold
4,779
﹤0.01% 2687
2021
Q3
$314K Sell
4,779
-900
-16% -$57.2K ﹤0.01% 3113
2021
Q2
$353K Buy
5,679
+885
+18% +$53.8K ﹤0.01% 3005
2021
Q1
$279K Sell
4,794
-252
-5% -$15.2K ﹤0.01% 2961
2020
Q4
$311K Sell
5,046
-1,575
-24% -$89.8K ﹤0.01% 2973
2020
Q3
$365K Sell
6,621
-1,284
-16% -$69.2K ﹤0.01% 2467
2020
Q2
$407K Buy
7,905
+900
+13% +$45.2K ﹤0.01% 2370
2020
Q1
$311K Buy
7,005
+795
+13% +$40.1K ﹤0.01% 2177
2019
Q4
$331K Hold
6,210
﹤0.01% 2889
2019
Q3
$289K Hold
6,210
﹤0.01% 2705
2019
Q2
$312K Sell
6,210
-225
-3% -$11.1K ﹤0.01% 2694
2019
Q1
$330K Hold
6,435
﹤0.01% 2488
2018
Q4
$302K Sell
6,435
-846
-12% -$43.4K ﹤0.01% 2392
2018
Q3
$407K Hold
7,281
﹤0.01% 2418
2018
Q2
$367K Sell
7,281
-1,299
-15% -$64.4K ﹤0.01% 2471
2018
Q1
$422K Sell
8,580
-180
-2% -$9.24K ﹤0.01% 2283
2017
Q4
$451K Buy
8,760
+30
+0.3% +$1.54K ﹤0.01% 2326
2017
Q3
$455K Sell
8,730
-360
-4% -$18.5K ﹤0.01% 2314
2017
Q2
$470K Sell
9,090
-345
-4% -$17.4K ﹤0.01% 2304
2017
Q1
$475K Buy
9,435
+1,176
+14% +$58.2K ﹤0.01% 2120
2016
Q4
$385K Sell
8,259
-5,430
-40% -$258K ﹤0.01% 2217
2016
Q3
$682K Sell
13,689
-7,194
-34% -$365K ﹤0.01% 1973
2016
Q2
$1M Buy
20,883
+531
+3% +$25.3K ﹤0.01% 1828
2016
Q1
$929K Buy
20,352
+129
+0.6% +$6.04K ﹤0.01% 1785
2015
Q4
$1.09M Sell
20,223
-22,752
-53% -$1.2M ﹤0.01% 1677
2015
Q3
$2.12M Buy
42,975
+22,881
+114% +$1.31M ﹤0.01% 1275
2015
Q2
$1.17M Sell
20,094
-933,621
-98% -$54.5M ﹤0.01% 1598
2015
Q1
$54.8M Buy
953,715
+936,225
+5,353% +$51.2M 0.06% 257
2014
Q4
$883K Sell
17,490
-247,761
-93% -$12.1M ﹤0.01% 1784
2014
Q3
$12.4M Buy
265,251
+7,185
+3% +$324K 0.01% 711
2014
Q2
$11.6M Buy
258,066
+9,816
+4% +$422K 0.01% 749
2014
Q1
$10.5M Buy
248,250
+86,202
+53% +$3.61M 0.01% 640
2013
Q4
$6.38M Buy
162,048
+79,776
+97% +$2.99M 0.01% 752
2013
Q3
$2.92M Buy
82,272
+3,495
+4% +$123K ﹤0.01% 990
2013
Q2
$2.62M Buy
+78,777
New +$2.62M ﹤0.01% 989

Other funds holding IHE

Bank of Montreal's IHE Position: Q2 2026 in Review

Bank of Montreal reduced its iShares US Pharmaceuticals ETF (IHE) stake by 0.27% in Q2 2026, selling an estimated $1.89K and leaving 7,820 shares worth $774K. The position accounts for ﹤0.01% of the portfolio, ranked #2219.

Bank of Montreal first reported a position in IHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $54.8M in Q1 2015. 201 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Bank of Montreal held 7,820 shares of iShares US Pharmaceuticals ETF worth $774K as of Q2 2026.
  • Bank of Montreal sold 21 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $1.89K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2219 holding.
  • Bank of Montreal first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's iShares US Pharmaceuticals ETF position peaked at $54.8M in Q1 2015.
  • 201 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.